Watch our Dolphins Deep Dive live stream as the South Florida Sun Sentinel’s Chris Perkins and David Furones discussed Quinn Ewers’ future and weighed in on if Mike McDaniel should return. On ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

A Guardian ad Litem acts as a neutral advocate for children in family court, between mothers and fathers fighting for custody.

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

Compromise is key to keeping a team humming along. Say one person wants an inrunner electric motor, and the other prefers outrunner. What to do? Well, if you work at [Deep Drive], the compromise ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

December 23, 2025 • As soon as Alternate Realities publishes, Zach Mack calls his dad to hear his reactions to the series. The conversation takes an unexpected turn, launching them into another ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

In the world of tough, reliable timepieces built for guys who push limits—whether that's exploring underwater caves or just appreciating gear that can handle anything—Zenith has stepped up its game.